CIBC Bancorp USA’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
CIBC Bancorp USA's BSX Position: Q3 2026 in Review
CIBC Bancorp USA reduced its Boston Scientific (BSX) stake by 48% in Q3 2026, selling an estimated $15.7M and leaving 367,322 shares worth $16M. The position accounts for 0.02% of the portfolio, ranked #444.
CIBC Bancorp USA first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $122M in Q1 2026. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.
- CIBC Bancorp USA held 367,322 shares of Boston Scientific worth $16M as of Q3 2026.
- CIBC Bancorp USA sold 338,954 Boston Scientific shares in Q3 2026, an estimated $15.7M.
- Boston Scientific made up 0.02% of CIBC Bancorp USA's portfolio in Q3 2026, its #444 holding.
- CIBC Bancorp USA first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
- CIBC Bancorp USA's Boston Scientific position peaked at $122M in Q1 2026.
- 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.